Pharmaceutical giant Eli Lilly said it will now move “with urgency” toward getting regulatory approval for orforglipron.
Source link

You May Also Like
Posted in
Markets
Nio’s stock dives as EV maker raises $1 billion at shareholders’ expense
Posted by
Admin
More From Author
Posted in
Travel
October credit card transfer bonuses: What to transfer and book right now
Posted by
Admin